Motilal Oswal reiterated a "Buy" rating for Biocon with a price target of Rs520. The target has been revised but positive view on the stock remains intact.
News in Focus
Featured, India Business, Analyst View, Stock Markets, Biocon, India, Motilal Oswal, Pharmaceutical Sector
Motilal Oswal Financial Services has reiterated a Buy rating on Life Insurance Corporation, raising its target price to Rs 480, implying 24% upside from the current market price of Rs 388.
Featured, India Business, Analyst View, Stock Markets, Devyani International, India, Motilal Oswal, Retail Markets
Motilal Oswal Financial Services has reiterated a Buy rating on Devyani International, holding its target price at Rs 160, implying 35% upside from the current market price of Rs 118.
ICICI Securities has upgraded Eicher Motors to Buy from Hold, raising its target price to Rs 9,500 from Rs 7,400, implying 22% upside from the current market price of Rs 7,779.
The scale of the iPhone's reach is difficult to overstate. Apple now has more than 2.5 billion active devices in use worldwide, with well over 1.5 billion of those being iPhones specifically.
Featured, India Business, Analyst View, Stock Markets, Auto Sector, Hyundai Motor India, ICICI Securities, India
ICICI Securities has maintained a Buy rating on Hyundai Motor India, trimming its target price slightly to Rs 2,450 from Rs 2,475, still implying 21% upside from the current market price of Rs 2,01
Main Regional Stories
ICICI Securities has reiterated a Buy rating on Swiggy, maintaining a three-stage DCF-based target price of Rs 520, implying 81% upside from the current market price of Rs 287.
India’s residential real estate market has undergone a structural shift, delivering a rare combination of strong capital appreciation and rising rental yields across major cities between 2019 and Q2 2026.
Anand Rathi Share and Stock Brokers has maintained a Buy rating on Karnataka Bank with a 12-month target price of Rs 364, implying roughly 25% upside from the current share price of Rs 291.
ICICI Securities has retained a Buy rating on Mahindra Lifespace Developers, keeping its 12-month target price unchanged at Rs 450, implying 19% upside from the current market price of Rs 377.
